These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4409721)
1. [Histological variants of primary invasion of breast cancer]. Gordeladze AS Vopr Onkol; 1974 Oct; 20(7):8-13. PubMed ID: 4409721 [No Abstract] [Full Text] [Related]
2. [Histological margin and residual disease assessment for breast carcinoma]. Sigal-Zafrani B; Fourquet A; Vincent-Salomon A; Fréneaux P; Génin P; Rosty C; Sastre-Garau X Cancer Radiother; 2003 Nov; 7 Suppl 1():120s-123s. PubMed ID: 15124553 [TBL] [Abstract][Full Text] [Related]
3. [Developmental trends in breast pathology]. Böcker W Pathologe; 1997 Jan; 18(1):1-2. PubMed ID: 9157397 [No Abstract] [Full Text] [Related]
4. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"]. Contesso G J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846 [No Abstract] [Full Text] [Related]
5. [Early and "latent" breast cancer]. Gol'bert ZV; Ostrovtsev LD; Sorkin EE Vopr Onkol; 1981; 27(10):34-9. PubMed ID: 7303556 [TBL] [Abstract][Full Text] [Related]
6. [Surgical therapy strategies in carcinoma in situ of the breast]. Mosny DS Praxis (Bern 1994); 1998 Apr; 87(15):516-9. PubMed ID: 9608247 [TBL] [Abstract][Full Text] [Related]
7. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)]. Haase W Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043 [No Abstract] [Full Text] [Related]
9. More on breast cancer guidelines. Ramsay WR CMAJ; 1998 Jun; 158(11):1427, 1429; author reply 1429-30. PubMed ID: 9629099 [No Abstract] [Full Text] [Related]
10. More on breast cancer guidelines. Rieckenberg M CMAJ; 1998 Jun; 158(11):1426-7; author reply 1429-30. PubMed ID: 9629098 [No Abstract] [Full Text] [Related]
11. [Structural characteristics of the tumor and the state of the surrounding tissue in middle-aged and elderly breast cancer patients]. Ermilova VD; Korshikov SV Arkh Patol; 1981; 43(11):52-6. PubMed ID: 6274280 [TBL] [Abstract][Full Text] [Related]
12. Pathobiochemistry of connective tissue in breast cancer. Gay S; Gay RE Verh Dtsch Ges Pathol; 1985; 69():62-73. PubMed ID: 4096126 [No Abstract] [Full Text] [Related]
13. Essential parameters in breast cancer: histopathology reporting guidelines. Quinn CM; Lioe T Ir Med J; 2002 Jan; 95(1):8-11. PubMed ID: 11928793 [No Abstract] [Full Text] [Related]
14. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care]. Bässler R; Schnürch HG Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734 [No Abstract] [Full Text] [Related]
15. [Cytological changes in breast carcinoma in situ]. Stosiek U; Breitbach GP Zentralbl Gynakol; 1984; 106(6):407-10. PubMed ID: 6326431 [TBL] [Abstract][Full Text] [Related]
16. [Significance of hyperelastosis in proliferative lesions of the breast]. Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264 [No Abstract] [Full Text] [Related]
17. [Transplantation of human primary in-situ and invasive breast carcinoma in nude mice]. He L; Andersen JA Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):321-3. PubMed ID: 9387265 [TBL] [Abstract][Full Text] [Related]
18. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases]. Stosiek P Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563 [TBL] [Abstract][Full Text] [Related]